Vladimir A. Mikhaylov
Eternity Medicine Institute, UAE
Biography
Mikhaylov Vladimir was born on March 21, 1959 in Uglich, Yaroslavl province, Russia. In1982- has finished the Ryazan medical institute named after I.P. Pavlov. 1997 – 2000 - Head of Moscow Scientific-Practical Center of laser Medicine. 2000 – 2006 -General director of Scientific medical laser Center, Moscow. Since 2006 - private practices on family medicine in Moscow. 2013- Physician Contract with Eternity Medicine Institute, Dubai 1988- protected a degree of Ph.D. - Formation dublical anastomosis in surgery of intestinum and pancreas (Diploma – МД â„– 030634, Moscow, 01.07.1988). 1994 - received a degree Sci.D. - Use of low- level of laser radiation in treatment of oncology diseases (Diploma – Др â„– 002389, Moscow, 29.07.1994, â„– 36д/5). 2009 - Has been recognized as an International Medical Laser Specialist at class: Hon-IMeLas, Number: H-0017, Congress ISLSM, WFSLMS, Tokyo, November 27, 2009.In 1996 - was elected by the member International Advisory Board on the 1st. Congress of the World Association on Laser Therapy (WALT) in Jrusalem, Israel. In 1998 - was elected the Representative of the WALT in Russia and East Europe on the 2nd. Congress of the World Association on Laser Therapy (WALT) in USA. In 1999 was selected in Board of directors (EMLA), direction – oncology and angiology in Vienna, Austria. In 2000 - is selected by a member of editorial board of the “Laser Therapy”. In 2001- President of the VIIIth Congress of European medical laser association (EMLA), Moscow, Russia. In 2002 - is selected by in Task Force in IIId Congress of World Association for Laser Therapy (WALT), Tokyo Japan.2016 - Prof. Ming-Chien Kao AWARD (for the paper contributed to the journal LASER THERAPY(Vol.24-1, Jan.2015 issue).
Abstract
The mortality from the diseases due to the affection of vessels came out now on the first place. The use of the Intravenous laser blood irradiation (ILBI) within the last 30 years showed its high efficiency in a treatment of diseases of vessels and heart, and other system diseases. Therefore ILBI as the method of the system impact on the blood system, allows to lower the lethality and to increase the life expectancy.The lasers used for treatment of various diseases, the waves having length of 630-640 nanometers are the most effective for the direct impact on the blood and the vascular wall. The energy of the waves of this length is absorbed by oxygen, improves the microcirculation in tissues, changes the viscosity of the blood and affects the wall of vessels.